An Integrated Clinical Microbiology Service Ensures Optimal Early Empirical Antimicrobial Therapy for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reply

doi:doi:10.1086/656209

dc.contributor.author	Chen, Luke	en_US
dc.contributor.author	Anderson, Deverick	en_US
dc.contributor.author	Choi, Yong	en_US
dc.contributor.author	Sexton, Daniel	en_US
dc.date.accessioned	2011-06-21T17:27:22Z
dc.date.available	2011-06-21T17:27:22Z
dc.date.issued	2010	en_US
dc.identifier.citation	Herzke,Carrie;Chen,Luke F.;Anderson,Deverick J.;Choi,Yong;Sexton,Daniel J.;Kaye,Keith S.. 2010. An Integrated Clinical Microbiology Service Ensures Optimal Early Empirical Antimicrobial Therapy for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reply. Infection Control and Hospital Epidemiology 31(9): 983-983.	en_US
dc.identifier.issn	0899-823X	en_US
dc.identifier.uri	http://hdl.handle.net/10161/4158
dc.description.abstract		en_US
dc.language.iso	en_US	en_US
dc.publisher	UNIV CHICAGO PRESS	en_US
dc.relation.isversionof	doi:10.1086/656209	en_US
dc.subject	public, environmental & occupational health	en_US
dc.subject	infectious diseases	en_US
dc.title	An Integrated Clinical Microbiology Service Ensures Optimal Early Empirical Antimicrobial Therapy for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reply	en_US
dc.title.alternative		en_US
dc.description.version	Version of Record	en_US
duke.date.pubdate	2010-9-0	en_US
duke.description.endpage	983	en_US
duke.description.issue	9	en_US
duke.description.startpage	983	en_US
duke.description.volume	31	en_US
dc.relation.journal	Infection Control and Hospital Epidemiology	en_US